Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 55% ± 20% | |
lung | 15 studies | 35% ± 11% | |
eye | 11 studies | 32% ± 13% | |
intestine | 9 studies | 24% ± 8% | |
kidney | 7 studies | 29% ± 10% | |
heart | 6 studies | 49% ± 17% | |
pancreas | 4 studies | 31% ± 14% | |
peripheral blood | 4 studies | 21% ± 9% | |
adipose | 4 studies | 51% ± 25% | |
uterus | 3 studies | 38% ± 9% | |
breast | 3 studies | 25% ± 6% | |
liver | 3 studies | 41% ± 22% | |
bone marrow | 3 studies | 29% ± 14% | |
skin | 3 studies | 22% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 46428.49 | 2642 / 2642 | 100% | 139.25 | 703 / 705 |
intestine | 100% | 31540.92 | 966 / 966 | 99% | 107.09 | 524 / 527 |
stomach | 99% | 21689.10 | 356 / 359 | 99% | 115.22 | 284 / 286 |
lung | 100% | 65526.40 | 577 / 578 | 98% | 70.84 | 1130 / 1155 |
skin | 100% | 22892.84 | 1806 / 1809 | 98% | 132.80 | 461 / 472 |
kidney | 100% | 24372.04 | 89 / 89 | 97% | 106.09 | 878 / 901 |
esophagus | 98% | 33917.83 | 1413 / 1445 | 99% | 122.98 | 182 / 183 |
breast | 100% | 49062.20 | 459 / 459 | 96% | 57.16 | 1076 / 1118 |
thymus | 100% | 37813.40 | 653 / 653 | 96% | 61.76 | 579 / 605 |
prostate | 100% | 23508.88 | 244 / 245 | 95% | 57.60 | 475 / 502 |
uterus | 100% | 27867.85 | 170 / 170 | 92% | 42.82 | 422 / 459 |
bladder | 100% | 25877.29 | 21 / 21 | 91% | 57.93 | 458 / 504 |
adrenal gland | 100% | 39396.80 | 258 / 258 | 90% | 55.37 | 207 / 230 |
liver | 89% | 15108.40 | 201 / 226 | 99% | 74.92 | 402 / 406 |
pancreas | 79% | 9531.89 | 258 / 328 | 99% | 98.89 | 177 / 178 |
ovary | 100% | 28064.37 | 180 / 180 | 73% | 25.95 | 316 / 430 |
adipose | 100% | 64468.13 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 34352.88 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 36770.83 | 860 / 861 | 0% | 0 | 0 / 0 |
spleen | 100% | 20018.91 | 240 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 105.35 | 77 / 80 |
muscle | 91% | 11944.53 | 731 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 84% | 38.66 | 38 / 45 |
lymph node | 0% | 0 | 0 / 0 | 69% | 24.11 | 20 / 29 |
peripheral blood | 19% | 6396.35 | 176 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_0021556 | Biological process | central nervous system formation |
GO_0000281 | Biological process | mitotic cytokinesis |
GO_0051693 | Biological process | actin filament capping |
GO_0060390 | Biological process | regulation of SMAD protein signal transduction |
GO_0032743 | Biological process | positive regulation of interleukin-2 production |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
GO_0007009 | Biological process | plasma membrane organization |
GO_0007417 | Biological process | central nervous system development |
GO_0071709 | Biological process | membrane assembly |
GO_1903076 | Biological process | regulation of protein localization to plasma membrane |
GO_0043001 | Biological process | Golgi to plasma membrane protein transport |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005730 | Cellular component | nucleolus |
GO_0005886 | Cellular component | plasma membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0030864 | Cellular component | cortical actin cytoskeleton |
GO_0014731 | Cellular component | spectrin-associated cytoskeleton |
GO_0032437 | Cellular component | cuticular plate |
GO_0030673 | Cellular component | axolemma |
GO_0005829 | Cellular component | cytosol |
GO_0014069 | Cellular component | postsynaptic density |
GO_0005737 | Cellular component | cytoplasm |
GO_0042995 | Cellular component | cell projection |
GO_0030054 | Cellular component | cell junction |
GO_0031430 | Cellular component | M band |
GO_0008091 | Cellular component | spectrin |
GO_0005543 | Molecular function | phospholipid binding |
GO_0045296 | Molecular function | cadherin binding |
GO_0051020 | Molecular function | GTPase binding |
GO_0005200 | Molecular function | structural constituent of cytoskeleton |
GO_0051015 | Molecular function | actin filament binding |
GO_0003723 | Molecular function | RNA binding |
GO_0030506 | Molecular function | ankyrin binding |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
Gene name | SPTBN1 |
Protein name | Alternative protein SPTBN1 Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1) Spectrin beta chain Spectrin, beta, non-erythrocytic 1, isoform CRA_c (cDNA FLJ55845, highly similar to Spectrin beta chain, brain 1) Spectrin beta, non-erythrocytic 1 Uncharacterized protein SPTBN1 |
Synonyms | hCG_17370 HEL102 SPTB2 |
Description | FUNCTION: Fodrin, which seems to be involved in secretion, interacts with calmodulin in a calcium-dependent manner and is thus candidate for the calcium-dependent movement of the cytoskeleton at the membrane. Plays a critical role in central nervous system development and function. . |
Accessions | A0A087WUZ3 ENST00000389980.7 F8W6C1 ENST00000615901.4 ENST00000333896.5 [Q01082-3] B4DIF8 L8ECA0 Q53RC4 ENST00000356805.9 [Q01082-1] K9MS24 B2ZZ89 Q01082 |